Altered calcium homeostasis is correlated with the presence of metabolic syndrome and diabetes in middle-aged and elderly Korean subjects: The Chungju Metabolic Disease Cohort study (CMC study)

Atherosclerosis

Volumn 212, Issue 2, 2010, Pages 674-681

  Kim, Mee Kyoung ^a   Kim, Guilsun ^a   Jang, Eun Hee ^a   Kwon, Hyuk Sang ^a   Baek, Ki Hyun ^a   Oh, Ki Won ^b   Lee, Jin Hee ^a   Yoon, Kun Ho ^a   Lee, Won Chul ^a   Lee, Kang Woo ^a   Son, Ho Young ^a   Kang, Moo Il ^a  

^a The Catholic University of Korea   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Diabetes; Metabolic syndrome; Serum calcium

Indexed keywords

25 HYDROXYVITAMIN D; ALBUMIN; CALCIUM; PARATHYROID HORMONE;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; CALCIUM BLOOD LEVEL; CALCIUM HOMEOSTASIS; COHORT ANALYSIS; CONFIDENCE INTERVAL; CORRELATION ANALYSIS; DIABETES MELLITUS; FEMALE; HUMAN; MALE; METABOLIC SYNDROME X; NORMAL HUMAN; PREVALENCE; PRIORITY JOURNAL; RISK; RURAL AREA;

AGED; ALBUMINS; CALCIUM; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FEMALE; HUMANS; KOREA; MALE; METABOLIC SYNDROME X; MIDDLE AGED; ODDS RATIO; PREVALENCE; RISK;

EID: 77957691198     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.07.005     Document Type: Article

References (34)

1. Hagström E., Lundgren E., Rastad J., Hellman P. Metabolic abnormalities in patients with normocalcemic hyperparathyroidism detected at a population-based screening. Eur J Endocrinol 2006, 155:33-39.
2. Hagström E., Lundgren E., Lithell H., et al. Normalized dyslipidaemia after parathyroidectomy in mild primary hyperparathyroidism: population-based study over five years. Clin Endocrinol 2002, 56:253-260.
3. Ahlström T., Hagström E., Larsson A., et al. Correlation between plasma calcium, parathyroid hormone (PTH) and the metabolic syndrome (MetS) in a community-based cohort of men and women. Clin Endocrinol 2009, 71:673-678.
4. Hjelmesaeth J., Hofsø D., Aasheim E.T., et al. Parathyroid hormone, but not vitamin D, is associated with the metabolic syndrome in morbidly obese women and men: a cross-sectional study. Cardiovasc Diabetol 2009, 8:7.
5. Reis J.P., von Mühlen D., Kritz-Silverstein D., Wingard D.L., Barrett-Connor E. Vitamin D, parathyroid hormone levels, and the prevalence of metabolic syndrome in community-dwelling older adults. Diabetes Care 2007, 30:1549-1555.
6. Kim MK, Kang MI, Oh KW, et al. The association of serum vitamin D level with presence of metabolic syndrome and hypertension in middle-aged Korean subjects. Clin Endocrinol; in press.
7. Lee D.M., Rutter M.K., O'Neill T.W., et al. Vitamin D, parathyroid hormone and the metabolic syndrome in middle-aged and older European men. Eur J Endocrinol 2009, 161:947-954. European Male Ageing Study Group.
8. Kesteloot H., Geboers J. Calcium and blood pressure. Lancet 1982, 1:813-815.
9. Lind L., Jakobsson S., Lithell H., Wengle B., Ljunghall S. Relation of serum calcium concentration to metabolic risk factors for cardiovascular disease. BMJ 1988, 297:960-963.
10. Jorde R., Sundsfjord J., Fitzgerald P., Bønaa K.H. Serum calcium and cardiovascular risk factors and diseases: the Tromsø study. Hypertension 1999, 34:484-490.
11. De Bacquer D., De Henauw S., De Backer G., Kornitzer M. Epidemiological evidence for an association between serum calcium and serum lipids. Atherosclerosis 1994, 108:193-200.
12. Wareham N.J., Byrne C.D., Carr C., et al. Glucose intolerance is associated with altered calcium homeostasis: a possible link between increased serum calcium concentration and cardiovascular disease mortality. Metabolism 1997, 46:1171-1177.
13. Hagström E., Hellman P., Lundgren E., Lind L., Arnlöv J. Serum calcium is independently associated with insulin sensitivity measured with euglycaemic-hyperinsulinaemic clamp in a community-based cohort. Diabetologia 2007, 50:317-324.
14. Sun G., Vasdev S., Martin G.R., Gadag V., Zhang H. Altered calcium homeostasis is correlated with abnormalities of fasting serum glucose, insulin resistance, and beta-cell function in the Newfoundland population. Diabetes 2005, 54:3336-3339.
15. Lind L., Skarfors E., Berglund L., Lithell H., Ljunghall S. Serum calcium: a new, independent, prospective risk factor for myocardial infarction in middle-aged men followed for 18 years. J Clin Epidemiol 1997, 50:967-973.
16. Taylor W.H., Khaleeli A.A. Coincident diabetes mellitus and primary hyperparathyroidism. Diabetes Metab Res Rev 2001, 17:175-180.
17. Levy J., Stern Z., Gutman A., et al. Plasma calcium and phosphate levels in an adult noninsulin-dependent diabetic population. Calcif Tissue Int 1986, 39:316-318.
18. Procopio M., Magro G., Cesario F., et al. The oral glucose tolerance test reveals a high frequency of both impaired glucose tolerance and undiagnosed Type 2 diabetes mellitus in primary hyperparathyroidism. Diabet Med 2002, 19:958-961.
19. Ahn Y.J., Lee J.E., Cho N.H., et al. Validation and calibration of semi-quantitative food frequency questionnaire. Korean J Community Nutr 2004, 9:173-182.
20. Matthews D.R., Hosker J.P., Rudenski A.S., et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
21. Grundy S.M., Cleeman J.I., Daniels S.R., et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart. Lung, and Blood Institute Scientific Statement. Circulation 2005, 112:2735-2752. American Heart Association; National Heart, Lung, and Blood Institute.
22. Curry D.L., Bennett L.L., Grodsky G.M. Requirement for calcium ion in insulin secretion by the perfused rat pancreas. Am J Physiol 1968, 214:174-178.
23. Rasouli M., Kiasari A.M. Serum calcium and phosphorus associate with the occurrence and severity of angiographically documented coronary heart disease, possibly through correlation with atherogenic (apo)lipoproteins. Clin Chem Lab Med 2006, 44:43-50.
24. Jendryczko A., Pardela M. Abnormal effect of sera from patients with atherosclerosis on calcium influx into normal erythrocytes. Cor Vasa 1993, 34:428-433.
25. Zemel M.B., Shi H., Greer B., Dirienzo D., Zemel P.C. Regulation of adiposity by dietary calcium. FASEB J 2000, 14:1132-1138.
26. Sampath V., Havel P.J., King J.C. Calcium supplementation does not alter lipid oxidation or lipolysis in overweight/obese women. Obesity 2008, 16:2400-2404.
27. Taniguchi A., Kataoka K., Kono T., et al. Parathyroid hormone-induced lipolysis in human adipose tissue. J Lipid Res 1987, 28:490-494.
28. McCarty M.F., Thomas C.A. PTH excess may promote weight gain by impeding catecholamine-induced lipolysis-implications for the impact of calcium, vitamin D, and alcohol on body weight. Med Hypotheses 2003, 61:535-542.
29. Pittas A.G., Lau J., Hu F.B., Dawson-Hughes B. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 2007, 92:2017-2029.
30. Cho G.J., Park H.T., Shin J.H., et al. Calcium intake is inversely associated with metabolic syndrome in postmenopausal women: Korea National Health and Nutrition Survey, 2001 and 2005. Menopause 2009, 16:992-997.
31. Rojhani A., Kies C.V. Selected nutrient intakes and blood serum mineral concentrations of elderly humans fed regular and sweet acidophilus milks. J Nutr Elder 1994, 13:35-56.
32. Block G.A., Spiegel D.M., Ehrlich J., et al. Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis. Kidney Int 2005, 68:1815-1824.
33. Reid IR, Bolland MJ, Grey A. Does calcium supplementation increase cardiovascular risk? Clin Endocrinol 2010; in press.
34. Bikle D. Nonclassic actions of vitamin D. J Clin Endocrinol Metab 2009, 94:26-34.